New imaging vs standard biopsy for Sjögren's diagnosis
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial compares a new, quick imaging method (called full-field optical coherence tomography) with the standard lab analysis of a saliva gland biopsy. It may help diagnose Sjögren's syndrome faster and with less discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your doctor suspects you have Sjögren's syndrome (a condition that causes dry eyes and dry mouth).
- You have already been scheduled for a minor salivary gland biopsy (a small tissue sample from your lip or cheek).
- You are not having a temporal artery biopsy at the same time (a biopsy of a blood vessel in your temple).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special, very high-frequency ultrasound to take detailed images of the small glands that can be affected in Sjögren's syndrome. The goal is to see if this new ultrasound technique can help doctors diagnose Sjögren's more accurately.
This study looks at how well your salivary glands work and if there is a connection with a special scan called sialoscintigraphy. It may help people with or without dry mouth symptoms and a Sjogren's diagnosis.
This study follows people who may have Sjögren’s disease to better understand how to diagnose it. If you have symptoms like dry eyes or dry mouth, this could help researchers confirm the diagnosis and learn what tests best explain it.
This trial tests a new way to measure dry mouth (xerostomia) in people with Sjögren's syndrome using a small strip of paper placed inside the cheek. If it works, it could help doctors diagnose dry mouth more easily.
This study follows people with Sjogren’s disease to understand how it develops and how symptoms naturally change over time. The goal is to improve understanding and future care rather than provide a new immediate treatment.
This trial tests an experimental drug called R-2487 for people with Sjogren's syndrome. It looks at safety and how well the drug works, and may offer a new treatment option.
Hear when a new Sjogren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.